Manifest Investing

Company	Ticker	Sector \| Industry	Quality	PAR
Jazz Pharmaceuticals	JAZZ	Healthcare \| Biotechnology	39	6.4%

Current Price (10/31 4:00PM EDT)			$137.64
Projected Return on Value (PROVE)			22.0%

Expected Income Statement
Current Sales			4,086.8
Sales Growth Forecast			6.2%
Net Profit Margin			30.4%

Projected Shares Outstanding			68.76
EPS - Five year Forecast			$24.42
Average P/E Ratio			7.7
Projected Average Price			$188.06

Price Appreciation (Annualized)			6.4%
Annual Dividend Yield			0.0%
Projected Annual Return			6.4%

Quality
Financial Strength			43	10.7
EPS Stability			43	10.8
Industry Sales Growth Rate			15.0%	5.2
Industry Net Profit Margin			30.0%	12.7
Calculated Quality Rating			39.3

Fundamental Data Updated: 08/29/2025

MIPAR	9.3%
Sweet Spot	14.3% - 19.3%

Quality Legend:
Blue	Excellent with quality greater than 80.
Green	Good with quality between 60 and 80.
Neutral	Average or below average with quality between 20 and 60.
Red	Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green	PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow	PAR is above the target range of MIPAR +10%, currently 10.1%
PAR	Projected Annual Return
MIPAR	The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
*	Not covered by Value Line Standard Edition.
b	Uses price-to-book value for valuation purposes.
P/CF	Uses price-to-cash flow for valuation.